Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Hua Cai Road 26 Hao, Dong San Huan Road Er Duan, Chengdu, Sichuang, 610052, China.
J Transl Med. 2012 Aug 28;10:176. doi: 10.1186/1479-5876-10-176.
In China, high prevalence of HBV and HCV parallels with the growing epidemic of syphilis and HIV in the general population poses a great threat to blood safety. This study investigated the prevalence of serologic markers for transfusion transmissible infections (TTIs) among four Chinese blood centers.
We examined whole blood donations collected from January 2000 through December 2010 at four Chinese blood centers. Post-donation testing of TTIs (HIV, HBV, HCV and syphilis) were conducted using two different enzyme-linked immunosorbent assay kits for each seromarker. The prevalence of serologic markers for TTIs (%) was calculated and additional analysis was conducted to examine donor characteristics associated with positive TTIs serology.
Of the 4,366,283 donations, 60% were from first-time donors and 40% were from repeated donors. The overall prevalence of HIV, HBsAg, HCV and syphilis was 0.08%, 0.86%, 0.51% and 0.47%, respectively. The prevalence profile of TTIs varied among different blood centers and appeared at relatively high levels. Overall, the prevalence of HBsAg and HCV demonstrated a decline trend among four blood centers, while the prevalence of HIV and syphilis displayed three different trends: constantly steady, continually increasing and declining among different centers.
This study reflects the risk of TTIs has been greatly reduced in China, but blood transfusion remains an ongoing risk factor for the spread of blood-borne infections, and further work and improvements are needed to strengthen both safety and availability of blood in China.
在中国,HBV 和 HCV 的高流行率与梅毒和 HIV 在普通人群中的流行呈平行关系,这对血液安全构成了巨大威胁。本研究调查了中国四个血站输血传播感染(TTI)血清标志物的流行情况。
我们检查了 2000 年 1 月至 2010 年 12 月期间在中国四个血站采集的全血献血。对 TTI(HIV、HBV、HCV 和梅毒)进行了献血后检测,每个血清标志物使用两种不同的酶联免疫吸附试验试剂盒进行检测。计算了 TTI 血清标志物的流行率(%),并进行了额外的分析,以检查与 TTI 血清学阳性相关的供者特征。
在 4366283 份献血中,60%来自首次献血者,40%来自重复献血者。HIV、HBsAg、HCV 和梅毒的总流行率分别为 0.08%、0.86%、0.51%和 0.47%。不同血站的 TTI 流行情况不同,且呈相对较高水平。总体而言,四个血站的 HBsAg 和 HCV 流行率呈下降趋势,而 HIV 和梅毒的流行率呈现三种不同趋势:不同中心之间持续稳定、持续增加和下降。
本研究反映了中国 TTI 的风险已大大降低,但输血仍然是传播血源性感染的持续风险因素,需要进一步努力和改进,以加强中国的血液安全性和可用性。